Centessa Pharmaceuticals plc (CNTA) Tops Q2 EPS by 22c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Citi maintains neutral stance on European equities despite rally
• Morgan Stanley sees quality stocks and AI adopters leading market